<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Dientamoeba fragilis</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Dientamoeba fragilis</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Dientamoeba fragilis</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Peter F Weller, MD, MACP</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Karin Leder, MBBS, FRACP, PhD, MPH, DTMH</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Edward T Ryan, MD, DTMH</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Milana Bogorodskaya, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Apr 26, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span><em>Dientamoeba fragilis</em> is an anaerobic intestinal protozoan parasite. Historically, this organism was among a group of enteric protozoan parasites beginning with <em>Giardia duodenalis </em>(previously<em> G. lamblia</em>) that were initially believed to be solely commensals and not capable of causing symptomatic illness. While <em>G. duodenalis</em> is a recognized cause of symptomatic infections, the pathogenicity of <em>D. fragilis</em> has been controversial. It is now recognized that <em>D. fragilis</em>, although it does not uniformly result in symptomatic disease, may be associated as a potential cause or a co-pathogen contributing to clinical intestinal infections. (See  <a class="medical medical_review" href="/z/d/html/5723.html" rel="external">"Giardiasis: Epidemiology, clinical manifestations, and diagnosis"</a> and  <a class="medical medical_review" href="/z/d/html/5672.html" rel="external">"Blastocystis species"</a> and  <a class="medical medical_review" href="/z/d/html/5730.html" rel="external">"Nonpathogenic enteric protozoa"</a>.) </p><p>Contributing to this uncertainty have been the challenges of conventional microscopic fecal examinations to detect labile trophozoite stages of <em>D. fragilis</em>. Extended microscopic methods for fecal exams can increase diagnostic detection of <em>D. fragilis</em> trophozoites by experienced observers [<a href="#rid1">1</a>]. Expertise with these microscopy methods, however, is rarely available and, if lacking in prior studies, may have allowed many infections to go undiagnosed. With the development of molecular nucleic acid amplification test (NAAT) methods to detect nucleic acids from <em>D. fragilis</em> (and other fecal pathogens), there has been an increasing diagnostic detection of <em>D. fragilis</em> in subjects as well as expanding insights into routes contributing to fecal-oral transmission of this parasite. That all subjects infected with <em>D. fragilis</em> may not experience intestinal symptoms has engendered controversies whether <em>D. fragilis</em> is a pathogen or alternatively only a benign commensal parasite [<a href="#rid2">2,3</a>]. For instance, in some studies, detection of <em>D. fragilis</em> in stool has been observed more frequently among asymptomatic individuals than among symptomatic patients [<a href="#rid4">4-6</a>]. With the increasingly prevalent detection of <em>D. fragilis </em>based on sensitive NAAT fecal assays, it has been suggested that this organism may be part of a healthy intestinal microbiome [<a href="#rid7">7</a>]. </p><p class="headingAnchor" id="H2"><span class="h1">MICROBIOLOGY</span><span class="headingEndMark"> — </span>Ultrastructural, immunologic, and genetic analyses place <em>D. fragilis</em> in the family of protozoan flagellates, which includes <em>Trichomonas</em> [<a href="#rid2">2,8</a>]. Unlike other intestinal protozoan organisms that have both trophozoite and hardy cyst stages, for a long time <em>D. fragilis</em> was recognized to exist only as trophozoites. Trophozoites measure 7 to 12 micrometers in diameter, contain one or two nuclei, lack flagellae, and are minimally motile. However, cyst forms of <em>D. fragilis</em> have been identified in experimental mouse infections and in human fecal samples [<a href="#rid9">9</a>], suggesting that cysts may be a transmissible infectious form of this organism.</p><p>There is genetic evidence for two variants of <em>D. fragilis</em> (genotypes [1 and 2]). There is a strong predominance of genotype 1 in both humans and some animal hosts [<a href="#rid10">10</a>]. It is unknown if these two genotypes differ in their pathogenicity, although studies have shown very low levels of genetic variability across parasite isolates collected in various geographic areas and from both symptomatic and asymptomatic cases [<a href="#rid10">10</a>].</p><p>Although the pathogenicity of <em>D. fragilis</em> has been debated for many years, a study has shown that <em>D. fragilis</em> can cause nontissue invasive inflammatory colitis in mice [<a href="#rid11">11</a>]. While this study supports a primary potential pathogenic role for <em>D. fragilis</em>, it remains unclear whether the pathogen's symptomatic pathogenicity is due to intraluminal environmental and combinatorial interactions amongst co-resident microbes (eg, <em>Blastocystis</em> and <em>Dientamoeba</em>)<em> </em>[<a href="#rid12">12</a>]. Potential symptomatic infections may be due to polymicrobial "co-pathogens" in concert with nominally "commensal" intestinal protozoans, including <em>D. fragilis</em> and <em>Blastocystis</em>. As an example, individuals harboring <em>D. fragilis</em> have alterations in their associated intestinal microbiota [<a href="#rid12">12-15</a>] and mice intestinal bacterial flora can facilitate "commensal" protozoan integration into the gut microbiome depending on dietary intake [<a href="#rid16">16</a>]. </p><p class="headingAnchor" id="H2297329759"><span class="h1">TRANSMISSION</span><span class="headingEndMark"> — </span>As a fecally passed organism, <em>D. fragilis</em> transmission might occur whenever there are breaks in "fecal-oral" hygiene. For instance, in an outbreak of enteric illnesses following an episode of wastewater contamination of drinking water in Finland, <em>D. fragilis </em>was detected by polymerase chase reaction (PCR) in contaminated drinking water [<a href="#rid17">17</a>]. </p><p>Acquisition of <em>D. fragilis</em> by humans may include transmission from human and animal fecal sources. Applications of sensitive molecular detections of <em>D. fragilis</em> are also increasingly detecting <em>D. fragilis</em> in nonhuman hosts. Sheep, pigs, cattle, and nonhuman primates have been identified as natural hosts of the genotypes found in humans, suggesting zoonotic potential for human transmission [<a href="#rid18">18,19</a>]. Likewise, urban rats studied in Madrid, Spain [<a href="#rid20">20</a>] and pet budgerigars [<a href="#rid21">21</a>] may be local sources of <em>D. fragilis</em>. Another study from the Czech Republic investigating asymptomatic humans and their pets utilized real-time PCR (qPCR) assays of feces and found <em>D. fragilis</em> in 24 percent of 296 human subjects and also in some of their pets, including dogs, rabbits, horses, a cat, and a guinea pig [<a href="#rid22">22</a>].</p><p class="headingAnchor" id="H42791474"><span class="h1">PATHOGENESIS</span><span class="headingEndMark"> — </span>Infections with <em>D. fragilis</em> are acquired by the fecal-oral route, but how the fragile trophozoites survive outside of the body and do not succumb to stomach acid following ingestion are not fully understood  (<a class="graphic graphic_figure graphicRef75072" href="/z/d/graphic/75072.html" rel="external">figure 1</a>). One hypothesis suggests that trophozoites might survive within and be ingested with the eggs of the pinworm <em>Enterobius vermicularis</em>. <em>D. fragilis</em> DNA has been recovered from pinworm eggs [<a href="#rid23">23,24</a>]. In some studied cohorts, there have been co-associations with <em>D. fragilis</em> and pinworm infections. In a study from Turkey, two-thirds of subjects with fecal studies positive for <em>D. fragilis</em> by microscopy and polymerase chase reaction (PCR) also had positive cellophane tape tests for <em>E. vermicularis </em>[<a href="#rid25">25</a>]. While concomitant pinworm infections might explain coinfection in some children, whether <em>E. vermi</em>cularis provides a privileged mode of <em>D. fragilis</em> transmission or whether such commonalities are indicative principally of ongoing breaks in fecal-oral hygiene remains to be ascertained [<a href="#rid23">23,24</a>]. Moreover, a role for pinworms in <em>D. fragilis</em> transmission does not explain most <em>D. fragilis</em> infections. Some studies have specifically failed to find a correlation between <em>D. fragilis</em> and <em>E. vermicularis </em>infections [<a href="#rid26">26</a>]. </p><p class="headingAnchor" id="H3"><span class="h1">EPIDEMIOLOGY</span><span class="headingEndMark"> — </span><em>D. fragilis</em> is distributed globally but estimates of its prevalence and disease associations are dependent on the diagnostic detection methods applied. Conventional fecal microscopy lacks sensitivity and under detects fecal <em>D. fragilis</em>. The increasing applications of molecular nucleic acid amplification test (NAAT) methodologies for detection of <em>D. fragilis</em> and other organisms are expanding the detection of <em>D. fragilis</em> in both symptomatic and asymptomatic populations. In a Finnish study including refined microscopic criteria and polymerase chain reaction (PCR) testing, <em>D. fragilis</em> was found to be the most common intestinal protozoan [<a href="#rid27">27</a>]. In a study from the Czech Republic of 296 healthy subjects without gastrointestinal symptoms, 24 percent harbored fecal <em>D. fragilis</em> on reverse transcriptase PCR (RT-PCR) analyses [<a href="#rid22">22</a>]. In another study of healthy potential fecal donors for a fecal microbiota transplant program in Amsterdam found that 60 of 148 (40.5 percent) Dutch candidate donors were excluded due to asymptomatic fecal carriage of <em>D. fragilis</em> [<a href="#rid28">28</a>].</p><p>In addition to the increasing recognition of <em>D. fragilis</em> as an endemic organism in Europe, <em>D. fragilis</em> has been detected in populations including returned missionaries [<a href="#rid29">29</a>], military groups [<a href="#rid30">30</a>], and immigrants from other countries [<a href="#rid31">31</a>].</p><p>While <em>D. fragilis</em> has been identified in patients with traveler's diarrhea [<a href="#rid32">32,33</a>], its role in post-travel gastrointestinal symptoms is not clear. A study from Israel utilized a multiplex PCR fecal assay to detect six intestinal protozoan species in patients with persistent gastrointestinal symptoms both amongst those with and without a history of travel [<a href="#rid34">34</a>]. In those with a travel history, 18.7 percent were positive for <em>D. fragilis</em>, while in those without a travel history, 19.6 percent were positive for <em>D. fragilis</em>. </p><p class="headingAnchor" id="H4"><span class="h1">CLINICAL MANIFESTATIONS</span><span class="headingEndMark"> — </span>The clinical presentation with <em>D. fragilis</em> is variable. Many individuals with <em>D. fragilis</em> are asymptomatic; the most common symptomatic presentation consists of gastrointestinal illnesses. The incubation period prior to the onset of symptoms following infection is unknown, as is the proportion of infected people who remain asymptomatic. </p><p>In one systematic review of individuals with <em>D. fragilis</em> in stool, 6 to 86 percent had diarrhea [<a href="#rid3">3</a>]. In 11 studies of stool samples submitted to laboratories, 4 percent of individuals had <em>D. fragilis,</em> of whom 54 percent had diarrhea. </p><p>The parasite localizes in the colon and can cause colitis [<a href="#rid35">35</a>]. Common complaints in those who are symptomatic include abdominal pain, flatulence, acute and recurrent diarrhea, or loose stools [<a href="#rid2">2,26,35-40</a>]. In one review, most patients presented with diarrhea and abdominal pain, frequently lasting longer than a duration of two weeks [<a href="#rid41">41</a>]. In one study of Turkish patients infected with <em>D. fragilis</em>, symptoms included [<a href="#rid36">36</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Abdominal pain (81 percent)</p><p class="bulletIndent1"><span class="glyph">●</span>Diarrhea (72 percent)</p><p class="bulletIndent1"><span class="glyph">●</span>Anorexia (16 percent)</p><p class="bulletIndent1"><span class="glyph">●</span>Fatigue (9 percent)</p><p class="bulletIndent1"><span class="glyph">●</span>Nausea (6 percent)</p><p class="bulletIndent1"><span class="glyph">●</span>Weight loss (3 percent)</p><p class="bulletIndent1"><span class="glyph">●</span>Vomiting (3 percent)</p><p></p><p>In another study, patients with <em>D. fragilis</em> experienced abdominal pain (28 percent), anal itching (27 percent), watery diarrhea (19 percent), meteorism (16 percent), and nausea/loss of appetite (14 percent) [<a href="#rid42">42</a>]. Abdominal pain and diarrhea presumed to be attributable to <em>D. fragilis</em> infections may persist for several years [<a href="#rid2">2,26,36,38,39,43</a>]. <em>D. fragilis</em> infection may be observed in some patients fulfilling criteria for irritable bowel syndrome (IBS) [<a href="#rid44">44</a>], although one meta-analysis found no significant association [<a href="#rid45">45</a>]. (See  <a class="medical medical_review" href="/z/d/html/2630.html" rel="external">"Clinical manifestations and diagnosis of irritable bowel syndrome in adults"</a>.)</p><p>Children are susceptible to infection with <em>D. fragilis</em>, but clinical symptoms vary. For instance, a study of asymptomatic children in Brazil utilizing sensitive fecal polymerase chain reaction (PCR) analyses found 10.3 percent (16 of 156) harbored <em>D. fragilis</em> [<a href="#rid46">46</a>].Children also may present with clinical symptoms (especially diarrhea and abdominal pain) more frequently than adults; they may also have prolonged infection [<a href="#rid47">47,48</a>]. Peripheral blood eosinophilia may accompany <em>D. fragilis</em> infections [<a href="#rid31">31,35,39,42,49,50</a>], and an eosinophil-enriched colitis due to <em>D. fragilis</em> infection may be mistaken for allergic colitis [<a href="#rid35">35</a>]. Neither the mechanism of the eosinophilia nor any pathophysiologic sequelae of the eosinophilia are known. The presence of eosinophilia in this infection is in striking contrast with diseases caused by other intestinal protozoa, with the exception of <em>Isospora belli</em> infections. (See  <a class="medical medical_review" href="/z/d/html/5725.html" rel="external">"Epidemiology, clinical manifestations, and diagnosis of Cystoisospora (Isospora) infections"</a> and  <a class="medical medical_review" href="/z/d/html/5691.html" rel="external">"Approach to the patient with unexplained eosinophilia"</a>.)</p><p class="headingAnchor" id="H5"><span class="h1">DIAGNOSIS</span><span class="headingEndMark"> — </span>Conventional and real-time polymerase chain reaction (PCR) have significantly higher sensitivity and specificity than microscopy [<a href="#rid2">2,51-57</a>]. Multiplex PCR-based assays have been developed and are being increasingly used to concurrently detect <em>D. fragilis</em> as well as <em>Blastocystis</em>, <em>Cryptosporidium</em>, <em>Giardia</em>, <em>Entamoeba</em>, and other pathogens in human stool samples [<a href="#rid50">50,58,59</a>]. There are no available <em>D. fragilis</em> immunofluorescent or antigen assays. </p><p>The increased use of nucleic acid detection techniques has helped increase detection of <em>D. fragilis</em> compared with microscopy. A study from rural Venezuela noted a 40 percent prevalence of <em>D. fragilis</em> with use of combined microscopy-PCR compared with 16 percent for microscopy alone [<a href="#rid56">56</a>].</p><p>In many areas, microscopy remains the diagnostic test of choice due to lack of widely available alternatives. Microscopy detects trophozoites in microscopic examinations of fixed and stained stool samples [<a href="#rid2">2</a>]. Trophozoites are fragile and are not detectable on wet mounts, iodine-stained samples, or formalin-ethyl acetate concentrates [<a href="#rid36">36</a>]. Thus, fixation of stool samples in polyvinyl alcohol fixative, sodium acetate-acetic acid-formalin fixative, or Schaudinn's fixative is necessary, as is the use of permanent trichrome staining [<a href="#rid40">40,60</a>]. Giemsa-stained stool smears may also be helpful in detecting <em>D. fragilis</em> [<a href="#rid47">47</a>]. Many diagnostic laboratories lack the requisite procedures to detect <em>D. fragilis</em>, since trophozoites deteriorate rapidly and can therefore be missed by microscopy unless there is prompt fixation of the specimen [<a href="#rid60">60,61</a>]. In a report from Ottawa, Canada, 91 percent of healthy children had detectable serum antibodies to <em>D. fragilis</em>, suggesting that mild or subclinical infections were common during childhood (though cross-reactivity is possible) [<a href="#rid62">62</a>]. </p><p class="headingAnchor" id="H1074648100"><span class="h1">DIFFERENTIAL DIAGNOSIS</span></p><p class="bulletIndent1"><span class="glyph">●</span>Gastrointestinal symptoms – Other protozoal parasites including giardiasis and <em>Blastocystis</em> can cause similar symptoms of abdominal pain, diarrhea, and anorexia. These are distinguished from <em>D. fragilis</em> via stool microscopy, immunoassay, or polymerase chain reaction. (See  <a class="medical medical_review" href="/z/d/html/5723.html" rel="external">"Giardiasis: Epidemiology, clinical manifestations, and diagnosis"</a> and  <a class="medical medical_review" href="/z/d/html/5672.html" rel="external">"Blastocystis species"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Gastrointestinal symptoms and eosinophilia – Other causes of gastrointestinal symptoms and eosinophilia include isosporiasis, strongyloidiasis, ascariasis, and hookworm. Coinfection can occur; the diagnoses are distinguished by stool microscopy. (See  <a class="medical medical_review" href="/z/d/html/5714.html" rel="external">"Strongyloidiasis"</a> and  <a class="medical medical_review" href="/z/d/html/5673.html" rel="external">"Ascariasis"</a> and  <a class="medical medical_review" href="/z/d/html/5721.html" rel="external">"Hookworm infection"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Irritable bowel syndrome – Clinical manifestations of irritable bowel syndrome include chronic abdominal pain and altered bowel habits, including diarrhea or constipation. The diagnosis is established based on clinical criteria. (See  <a class="medical medical_review" href="/z/d/html/2630.html" rel="external">"Clinical manifestations and diagnosis of irritable bowel syndrome in adults"</a>.)</p><p></p><p class="headingAnchor" id="H6"><span class="h1">TREATMENT</span></p><p class="headingAnchor" id="H21483355"><span class="h2">Clinical approach</span><span class="headingEndMark"> — </span>While identification of <em>D. fragilis </em>in an asymptomatic individual requires no treatment, infections with <em>D. fragilis</em> should be treated when the organism is found as a sole potential pathogen in stool samples from patients with abdominal pain or diarrhea lasting for more than one week.</p><p>No large-scale randomized controlled trials have been performed to assess the effect of various antimicrobial agents in patients infected with <em>D. fragilis</em> [<a href="#rid63">63</a>]. Moreover, the increasing applications of nucleic acid amplification test (NAAT) polymerase chain reaction (PCR)-based diagnostic fecal testing for <em>D. fragilis</em> are revealing that therapies often fail to eradicate fecal excretion of the organism. There are several regimens that may be used to treat symptomatic <em>D. fragilis</em> infections, including [<a href="#rid39">39,48,64,65</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_general" data-topicid="9742" href="/z/d/drug information/9742.html" rel="external">Paromomycin</a> (25 to 35 mg/kg per day in three divided doses for seven days)</p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_general" data-topicid="9646" href="/z/d/drug information/9646.html" rel="external">Metronidazole</a> (500 to 750 mg three times a day for 10 days)</p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_general" data-topicid="9986" href="/z/d/drug information/9986.html" rel="external">Tetracycline</a> (500 mg [10 mg/kg] orally four times daily for 10 days) or <a class="drug drug_general" data-topicid="9393" href="/z/d/drug information/9393.html" rel="external">doxycycline</a> (100 mg [2 mg/kg] orally twice daily for 10 days)</p><p></p><p>In a study evaluating the in vitro susceptibility of <em>D. fragilis</em> to several antiparasitic agents, 5-nitroimidazole derivatives were found to be the most active compounds (including ornidazole, <a class="drug drug_general" data-topicid="10205" href="/z/d/drug information/10205.html" rel="external">tinidazole</a>, <a class="drug drug_general" data-topicid="9646" href="/z/d/drug information/9646.html" rel="external">metronidazole</a>, and <a class="drug drug_general" data-topicid="114899" href="/z/d/drug information/114899.html" rel="external">secnidazole</a>), followed by <a class="drug drug_general" data-topicid="10105" href="/z/d/drug information/10105.html" rel="external">nitazoxanide</a>, tetracyclines, furazolidone, <a class="drug drug_general" data-topicid="9742" href="/z/d/drug information/9742.html" rel="external">paromomycin</a>, and diloxanide furoate [<a href="#rid66">66</a>]. Benzimidazoles (<a class="drug drug_general" data-topicid="9371" href="/z/d/drug information/9371.html" rel="external">albendazole</a>, <a class="drug drug_general" data-topicid="9594" href="/z/d/drug information/9594.html" rel="external">mebendazole</a>) have no activity in vitro against <em>D. fragilis </em>[<a href="#rid67">67</a>].</p><p>A randomized, double-blinded study in Denmark evaluated 96 children with <em>D. fragilis</em> infection and chronic gastrointestinal symptoms (abdominal pain and/or diarrhea lasting greater than four weeks) treated with a 10-day course of either <a class="drug drug_general" data-topicid="9646" href="/z/d/drug information/9646.html" rel="external">metronidazole</a> or placebo [<a href="#rid68">68</a>]. Metronidazole did not significantly reduce gastrointestinal symptoms compared to placebo. Eradication of <em>D. fragilis</em> was significantly greater in the metronidazole group as assessed by PCR 14 days after completion of therapy, although PCR positivity rebounded by eight weeks after completion of therapy to levels comparable with those seen in placebo recipients [<a href="#rid68">68</a>]. Since the role of <em>D. fragilis</em> as the sole etiologic agent of the chronic gastrointestinal disease in these children remained uncertain, it is unclear whether the failure of metronidazole to lead to clinical improvement indicates its lack of efficacy against <em>D. fragilis</em>.</p><p>For colonic infections, <a class="drug drug_general" data-topicid="9742" href="/z/d/drug information/9742.html" rel="external">paromomycin</a>, a nonabsorbable aminoglycoside has higher intra-colonic concentrations than oral <a class="drug drug_general" data-topicid="9646" href="/z/d/drug information/9646.html" rel="external">metronidazole</a> that is well taken up in the proximal gastrointestinal tract to act systemically. Data suggest paromomycin is efficacious despite relatively weak in vitro susceptibility data as well as a lack of randomized controlled trial data [<a href="#rid41">41,69</a>]. One retrospective study utilizing fecal microscopy reported eradication rates of 98 percent for paromomycin versus 57 percent for metronidazole and 41 percent for no treatment [<a href="#rid70">70</a>]. In one study from Italy including 85 patients, the rate of clinical improvement was higher among those treated with paromomycin compared with metronidazole (100 versus 53 percent) [<a href="#rid42">42</a>]. </p><p class="headingAnchor" id="H1058301631"><span class="h2">Other agents</span><span class="headingEndMark"> — </span>In addition to <a class="drug drug_general" data-topicid="9646" href="/z/d/drug information/9646.html" rel="external">metronidazole</a>, other nitroimidazole agents with potential efficacy include <a class="drug drug_general" data-topicid="114899" href="/z/d/drug information/114899.html" rel="external">secnidazole</a>, ornidazole, and <a class="drug drug_general" data-topicid="10205" href="/z/d/drug information/10205.html" rel="external">tinidazole</a>.</p><p><a class="drug drug_general" data-topicid="114899" href="/z/d/drug information/114899.html" rel="external">Secnidazole</a> was evaluated in a study of 35 Turkish patients with <em>D. fragilis</em> infection; in all but one patient, the organism was eradicated, as judged by fecal microscopy, with a single dose of secnidazole, suggesting that secnidazole is effective in achieving parasitological and clinical cure [<a href="#rid36">36</a>].</p><p>Ornidazole (30 mg/kg single dose for children and 2 g single dose for adults) was superior to <a class="drug drug_general" data-topicid="9646" href="/z/d/drug information/9646.html" rel="external">metronidazole</a> in a randomized trial of 112 Turkish patients with respect to parasitologic cure (92.9 versus 69.6 percent, p = 0.001) and clinical cure (96.4 versus 76.8 percent, p = 0.001) [<a href="#rid71">71</a>].</p><p><a class="drug drug_general" data-topicid="10205" href="/z/d/drug information/10205.html" rel="external">Tinidazole</a> (2 g single dose) is more widely available than the above agents and is better tolerated than <a class="drug drug_general" data-topicid="9646" href="/z/d/drug information/9646.html" rel="external">metronidazole</a>; use of this agent is reasonable although data are limited. It may be effective in combination with <a class="drug drug_general" data-topicid="9742" href="/z/d/drug information/9742.html" rel="external">paromomycin</a> or other agents; further study is needed [<a href="#rid41">41,69</a>].</p><p class="headingAnchor" id="H7"><span class="h1">PREVENTION</span><span class="headingEndMark"> — </span>Since the mechanism of transmission of fecally derived <em>D. fragilis</em> is not fully understood, there are no specific guidelines on measures to prevent acquisition of infection with this organism. Screening of household members of <em>D. fragilis</em> patients has been suggested [<a href="#rid49">49,72</a>], especially in cases of relapsed infection. (See <a class="local">'Transmission'</a> above.)</p><p class="headingAnchor" id="H18561528"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Microbiology</strong> – <em>Dientamoeba fragilis</em> is an anaerobic intestinal protozoan parasite. It is a flagellate that produces trophozoites as well as cysts. Infection may be symptomatic or asymptomatic. (See <a class="local">'Introduction'</a> above and <a class="local">'Microbiology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Epidemiology</strong> – Infection is transmitted by the fecal-oral route. <em>D. fragilis</em> is distributed globally. Since many diagnostic laboratories lack the requisite procedures for detection, the prevalence is probably underestimated. (See <a class="local">'Transmission'</a> above and <a class="local">'Epidemiology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical manifestations</strong> – The incubation period and proportion of asymptomatic infected individuals are unknown. The parasite localizes in the colon and can cause colitis. Common symptoms include abdominal pain and acute and recurrent diarrhea. <em>D. fragilis</em> may present with peripheral eosinophilia and/or eosinophilic colitis. (See <a class="local">'Clinical manifestations'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Diagnosis</strong> – The diagnosis is made via detection of <em>D. fragilis</em> trophozoites in microscopic examinations of appropriately fixed and stained stool samples or by polymerase chain reaction (PCR)–based nucleic acid amplification test (NAAT) techniques and real-time PCR have significantly higher sensitivity and specificity than microscopy. (See <a class="local">'Diagnosis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Treatment</strong> – Treatment is warranted when the organism is found as a sole potential pathogen in stool samples in the setting of abdominal pain or diarrhea lasting more than one week. The optimal therapy is uncertain; we suggest treatment with <a class="drug drug_general" data-topicid="9646" href="/z/d/drug information/9646.html" rel="external">metronidazole</a> or <a class="drug drug_general" data-topicid="9742" href="/z/d/drug information/9742.html" rel="external">paromomycin</a> (<a class="grade" href="https:///uptodate/show/grade_6" rel="external">Grade 2C</a>). (See <a class="local">'Treatment'</a> above.)</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Ögren J, Dienus O, Matussek A. Optimization of routine microscopic and molecular detection of parasitic protozoa in SAF-fixed faecal samples in Sweden. Infect Dis (Lond) 2020; 52:87.</a></li><li><a class="nounderline abstract_t">Johnson EH, Windsor JJ, Clark CG. Emerging from obscurity: biological, clinical, and diagnostic aspects of Dientamoeba fragilis. Clin Microbiol Rev 2004; 17:553.</a></li><li><a class="nounderline abstract_t">Wong ZW, Faulder K, Robinson JL. Does Dientamoeba fragilis cause diarrhea? A systematic review. Parasitol Res 2018; 117:971.</a></li><li><a class="nounderline abstract_t">Krogsgaard LR, Engsbro AL, Stensvold CR, et al. The prevalence of intestinal parasites is not greater among individuals with irritable bowel syndrome: a population-based case-control study. Clin Gastroenterol Hepatol 2015; 13:507.</a></li><li><a class="nounderline abstract_t">Bruijnesteijn van Coppenraet LE, Dullaert-de Boer M, Ruijs GJ, et al. Case-control comparison of bacterial and protozoan microorganisms associated with gastroenteritis: application of molecular detection. Clin Microbiol Infect 2015; 21:592.e9.</a></li><li><a class="nounderline abstract_t">Hawash YA, Ismail KA, Saber T, et al. Dientamoeba fragilis Infection in Patients with Digestive and Non-Digestive Symptoms: A Case-Control Study. Korean J Parasitol 2020; 58:129.</a></li><li><a class="nounderline abstract_t">de Boer MD, Schuurs TA, Vermeer M, et al. Distribution and relevance of Dientamoeba fragilis and Blastocystis species in gastroenteritis: results from a case-control study. Eur J Clin Microbiol Infect Dis 2020; 39:197.</a></li><li><a class="nounderline abstract_t">Silberman JD, Clark CG, Sogin ML. Dientamoeba fragilis shares a recent common evolutionary history with the trichomonads. Mol Biochem Parasitol 1996; 76:311.</a></li><li><a class="nounderline abstract_t">Stark D, Garcia LS, Barratt JL, et al. Description of Dientamoeba fragilis cyst and precystic forms from human samples. J Clin Microbiol 2014; 52:2680.</a></li><li><a class="nounderline abstract_t">Cacciò SM. Molecular epidemiology of Dientamoeba fragilis. Acta Trop 2018; 184:73.</a></li><li><a class="nounderline abstract_t">El-Gayar EK, Mokhtar AB, Hassan WA. Study of the pathogenic potential of Dientamoeba fragilis in experimentally infected mice. Parasite Epidemiol Control 2016; 1:136.</a></li><li><a class="nounderline abstract_t">Dubik M, Pilecki B, Moeller JB. Commensal Intestinal Protozoa-Underestimated Members of the Gut Microbial Community. Biology (Basel) 2022; 11.</a></li><li><a class="nounderline abstract_t">Gotfred-Rasmussen H, Stensvold CR, Ingham AC, et al. Impact of Metronidazole Treatment and Dientamoeba Fragilis Colonization on Gut Microbiota Diversity. J Pediatr Gastroenterol Nutr 2021; 73:23.</a></li><li><a class="nounderline abstract_t">Krogsgaard LR, Andersen LO', Johannesen TB, et al. Characteristics of the bacterial microbiome in association with common intestinal parasites in irritable bowel syndrome. Clin Transl Gastroenterol 2018; 9:161.</a></li><li><a class="nounderline abstract_t">Sarzhanov F, Dogruman-Al F, Santin M, et al. Investigation of neglected protists Blastocystis sp. and Dientamoeba fragilis in immunocompetent and immunodeficient diarrheal patients using both conventional and molecular methods. PLoS Negl Trop Dis 2021; 15:e0009779.</a></li><li><a class="nounderline abstract_t">Wei Y, Gao J, Kou Y, et al. Commensal Bacteria Impact a Protozoan's Integration into the Murine Gut Microbiota in a Dietary Nutrient-Dependent Manner. Appl Environ Microbiol 2020; 86.</a></li><li><a class="nounderline abstract_t">Kauppinen A, Pitkänen T, Al-Hello H, et al. Two Drinking Water Outbreaks Caused by Wastewater Intrusion Including Sapovirus in Finland. Int J Environ Res Public Health 2019; 16.</a></li><li><a class="nounderline abstract_t">Cacciò SM, Sannella AR, Manuali E, et al. Pigs as natural hosts of Dientamoeba fragilis genotypes found in humans. Emerg Infect Dis 2012; 18:838.</a></li><li><a class="nounderline abstract_t">Yildiz İ, Erdem Aynur Z. First detection and molecular characterization of Dientamoeba fragilis in cattle. Zoonoses Public Health 2022; 69:897.</a></li><li><a class="nounderline abstract_t">Galán-Puchades MT, Trelis M, Sáez-Durán S, et al. One Health Approach to Zoonotic Parasites: Molecular Detection of Intestinal Protozoans in an Urban Population of Norway Rats, Rattus norvegicus, in Barcelona, Spain. Pathogens 2021; 10.</a></li><li><a class="nounderline abstract_t">Yetismis G, Yildirim A, Pekmezci D, et al. First report and genotyping of Dientamoeba fragilis in pet budgerigars (Melopsittacus undulatus), with zoonotic importance. Zoonoses Public Health 2022; 69:572.</a></li><li><a class="nounderline abstract_t">Jirků M, Kašparová A, Lhotská Z, et al. A Cross-Sectional Study on the Occurrence of the Intestinal Protist, Dientamoeba fragilis, in the Gut-Healthy Volunteers and Their Animals. Int J Mol Sci 2022; 23.</a></li><li><a class="nounderline abstract_t">Ögren J, Dienus O, Löfgren S, et al. Dientamoeba fragilis DNA detection in Enterobius vermicularis eggs. Pathog Dis 2013; 69:157.</a></li><li><a class="nounderline abstract_t">Röser D, Nejsum P, Carlsgart AJ, et al. DNA of Dientamoeba fragilis detected within surface-sterilized eggs of Enterobius vermicularis. Exp Parasitol 2013; 133:57.</a></li><li><a class="nounderline abstract_t">Yıldız İ, Ertuğ S, Tileklioğlu E, et al. Investigation of Dientamoeba fragilis Frequency in Faecal Samples of Patients with Enterobius vermicularis Infection by Polymerase Chain Reaction. Turkiye Parazitol Derg 2021; 45:195.</a></li><li><a class="nounderline abstract_t">Stark D, Beebe N, Marriott D, et al. Prospective study of the prevalence, genotyping, and clinical relevance of Dientamoeba fragilis infections in an Australian population. J Clin Microbiol 2005; 43:2718.</a></li><li><a class="nounderline abstract_t">Pietilä JP, Meri T, Siikamäki H, et al. Dientamoeba fragilis - the most common intestinal protozoan in the Helsinki Metropolitan Area, Finland, 2007 to 2017. Euro Surveill 2019; 24.</a></li><li><a class="nounderline abstract_t">Bénard MV, de Bruijn CMA, Fenneman AC, et al. Challenges and costs of donor screening for fecal microbiota transplantations. PLoS One 2022; 17:e0276323.</a></li><li><a class="nounderline abstract_t">McQuay RM. Parasitologic studies in a group of furloughed missionaries. I. Intestinal protozoa. Am J Trop Med Hyg 1967; 16:154.</a></li><li><a class="nounderline abstract_t">Oyofo BA, Peruski LF, Ismail TF, et al. Enteropathogens associated with diarrhea among military personnel during Operation Bright Star 96, in Alexandria, Egypt. Mil Med 1997; 162:396.</a></li><li><a class="nounderline abstract_t">Miguel L, Salvador F, Sulleiro E, et al. Clinical and Epidemiological Characteristics of Patients with Dientamoeba fragilis Infection. Am J Trop Med Hyg 2018; 99:1170.</a></li><li><a class="nounderline abstract_t">Stark D, Beebe N, Marriott D, et al. Dientamoeba fragilis as a cause of travelers' diarrhea: report of seven cases. J Travel Med 2007; 14:72.</a></li><li><a class="nounderline abstract_t">Calderaro A, Montecchini S, Rossi S, et al. Intestinal parasitoses in a tertiary-care hospital located in a non-endemic setting during 2006-2010. BMC Infect Dis 2014; 14:264.</a></li><li><a class="nounderline abstract_t">Gefen-Halevi S, Biber A, Gazit Z, et al. Persistent abdominal symptoms in returning travellers: clinical and molecular findings. J Travel Med 2022; 29.</a></li><li><a class="nounderline abstract_t">Cuffari C, Oligny L, Seidman EG. Dientamoeba fragilis masquerading as allergic colitis. J Pediatr Gastroenterol Nutr 1998; 26:16.</a></li><li><a class="nounderline abstract_t">Girginkardeşler N, Coşkun S, Cüneyt Balcioğlu I, et al. Dientamoeba fragilis, a neglected cause of diarrhea, successfully treated with secnidazole. Clin Microbiol Infect 2003; 9:110.</a></li><li><a class="nounderline abstract_t">Grendon JH, DiGiacomo RF, Frost FJ. Descriptive features of Dientamoeba fragilis infections. J Trop Med Hyg 1995; 98:309.</a></li><li><a class="nounderline abstract_t">Norberg A, Nord CE, Evengård B. Dientamoeba fragilis--a protozoal infection which may cause severe bowel distress. Clin Microbiol Infect 2003; 9:65.</a></li><li><a class="nounderline abstract_t">Preiss U, Ockert G, Broemme S, Otto A. On the clinical importance of Dientamoeba fragilis infections in childhood. J Hyg Epidemiol Microbiol Immunol 1991; 35:27.</a></li><li><a class="nounderline abstract_t">Stark D, Barratt J, Chan D, Ellis JT. Dientamoeba fragilis, the Neglected Trichomonad of the Human Bowel. Clin Microbiol Rev 2016; 29:553.</a></li><li><a class="nounderline abstract_t">Stark D, Barratt J, Roberts T, et al. A review of the clinical presentation of dientamoebiasis. Am J Trop Med Hyg 2010; 82:614.</a></li><li><a class="nounderline abstract_t">Clemente L, Pasut M, Carlet R, et al. Dientamoeba fragilis in the North-East of Italy: Prevalence study and treatment. Parasitol Int 2021; 80:102227.</a></li><li><a class="nounderline abstract_t">Windsor JJ, Rafay AM, Shenoy AK, Johnson EH. Incidence of Dientamoeba fragilis in faecal samples submitted for routine microbiological analysis. Br J Biomed Sci 1998; 55:172.</a></li><li><a class="nounderline abstract_t">Yakoob J, Jafri W, Beg MA, et al. Blastocystis hominis and Dientamoeba fragilis in patients fulfilling irritable bowel syndrome criteria. Parasitol Res 2010; 107:679.</a></li><li><a class="nounderline abstract_t">Rostami A, Riahi SM, Haghighi A, et al. The role of Blastocystis sp. and Dientamoeba fragilis in irritable bowel syndrome: a systematic review and meta-analysis. Parasitol Res 2017; 116:2361.</a></li><li><a class="nounderline abstract_t">Oliveira-Arbex AP, David ÉB, Cacciò SM, et al. Prevalence and genetic characterization of Dientamoeba fragilis in asymptomatic children attending daycare centers. Rev Inst Med Trop Sao Paulo 2021; 63:e39.</a></li><li><a class="nounderline abstract_t">Crotti D, D'Annibale ML, Fonzo G, et al. Dientamoeba fragilis is more prevalent than Giardia duodenalis in children and adults attending a day care centre in Central Italy. Parasite 2005; 12:165.</a></li><li><a class="nounderline abstract_t">Preiss U, Ockert G, Brömme S, Otto A. Dientamoeba fragilis infection, a cause of gastrointestinal symptoms in childhood. Klin Padiatr 1990; 202:120.</a></li><li><a class="nounderline abstract_t">Gray TJ, Kwan YL, Phan T, et al. Dientamoeba fragilis: a family cluster of disease associated with marked peripheral eosinophilia. Clin Infect Dis 2013; 57:845.</a></li><li><a class="nounderline abstract_t">Venturini E, Scarso S, Prelazzi GA, et al. Epidemiology and clinical features of intestinal protozoan infections detected by Real-time PCR in non-native children within an Italian tertiary care children's hospital: A cross-sectional study. Travel Med Infect Dis 2021; 43:102107.</a></li><li><a class="nounderline abstract_t">Stark D, Beebe N, Marriott D, et al. Detection of Dientamoeba fragilis in fresh stool specimens using PCR. Int J Parasitol 2005; 35:57.</a></li><li><a class="nounderline abstract_t">Stark D, Beebe N, Marriott D, et al. Evaluation of three diagnostic methods, including real-time PCR, for detection of Dientamoeba fragilis in stool specimens. J Clin Microbiol 2006; 44:232.</a></li><li><a class="nounderline abstract_t">Stark D, Al-Qassab SE, Barratt JL, et al. Evaluation of multiplex tandem real-time PCR for detection of Cryptosporidium spp., Dientamoeba fragilis, Entamoeba histolytica, and Giardia intestinalis in clinical stool samples. J Clin Microbiol 2011; 49:257.</a></li><li><a class="nounderline abstract_t">Calderaro A, Gorrini C, Montecchini S, et al. Evaluation of a real-time polymerase chain reaction assay for the detection of Dientamoeba fragilis. Diagn Microbiol Infect Dis 2010; 67:239.</a></li><li><a class="nounderline abstract_t">Maas L, Dorigo-Zetsma JW, de Groot CJ, et al. Detection of intestinal protozoa in paediatric patients with gastrointestinal symptoms by multiplex real-time PCR. Clin Microbiol Infect 2014; 20:545.</a></li><li><a class="nounderline abstract_t">Incani RN, Ferrer E, Hoek D, et al. Diagnosis of intestinal parasites in a rural community of Venezuela: Advantages and disadvantages of using microscopy or RT-PCR. Acta Trop 2017; 167:64.</a></li><li><a class="nounderline abstract_t">Friesen J, Fuhrmann J, Kietzmann H, et al. Evaluation of the Roche LightMix Gastro parasites multiplex PCR assay detecting Giardia duodenalis, Entamoeba histolytica, cryptosporidia, Dientamoeba fragilis, and Blastocystis hominis. Clin Microbiol Infect 2018; 24:1333.</a></li><li><a class="nounderline abstract_t">Stark D, Roberts T, Ellis JT, et al. Evaluation of the EasyScreen™ enteric parasite detection kit for the detection of Blastocystis spp., Cryptosporidium spp., Dientamoeba fragilis, Entamoeba complex, and Giardia intestinalis from clinical stool samples. Diagn Microbiol Infect Dis 2014; 78:149.</a></li><li><a class="nounderline abstract_t">Autier B, Gangneux JP, Robert-Gangneux F. Evaluation of the AllplexTM Gastrointestinal Panel-Parasite Assay for Protozoa Detection in Stool Samples: A Retrospective and Prospective Study. Microorganisms 2020; 8.</a></li><li><a class="nounderline abstract_t">Grendon JH, Digiacomo RF, Frost FJ. Dientamoeba fragilis detection methods and prevalence: a survey of state public health laboratories. Public Health Rep 1991; 106:322.</a></li><li><a class="nounderline abstract_t">Kappus KD, Lundgren RG Jr, Juranek DD, et al. Intestinal parasitism in the United States: update on a continuing problem. Am J Trop Med Hyg 1994; 50:705.</a></li><li><a class="nounderline abstract_t">Chan F, Stewart N, Guan M, et al. Prevalence of Dientamoeba fragilis antibodies in children and recognition of a 39 kDa immunodominant protein antigen of the organism. Eur J Clin Microbiol Infect Dis 1996; 15:950.</a></li><li><a class="nounderline abstract_t">Stark DJ, Beebe N, Marriott D, et al. Dientamoebiasis: clinical importance and recent advances. Trends Parasitol 2006; 22:92.</a></li><li class="breakAll">Drugs for Parasitic Infections, 3rd ed, The Medical Letter, New Rochelle, NY 2013.</li><li><a class="nounderline abstract_t">Nagata N, Marriott D, Harkness J, et al. Current treatment options for Dientamoeba fragilis infections. Int J Parasitol Drugs Drug Resist 2012; 2:204.</a></li><li><a class="nounderline abstract_t">Nagata N, Marriott D, Harkness J, et al. In vitro susceptibility testing of Dientamoeba fragilis. Antimicrob Agents Chemother 2012; 56:487.</a></li><li><a class="nounderline abstract_t">Stark D, Barratt JL, Roberts T, et al. Activity of benzimidazoles against Dientamoeba fragilis (Trichomonadida, Monocercomonadidae) in vitro and correlation of beta-tubulin sequences as an indicator of resistance. Parasite 2014; 21:41.</a></li><li><a class="nounderline abstract_t">Röser D, Simonsen J, Stensvold CR, et al. Metronidazole therapy for treating dientamoebiasis in children is not associated with better clinical outcomes: a randomized, double-blinded and placebo-controlled clinical trial. Clin Infect Dis 2014; 58:1692.</a></li><li><a class="nounderline abstract_t">Vandenberg O, Souayah H, Mouchet F, et al. Treatment of Dientamoeba fragilis infection with paromomycin. Pediatr Infect Dis J 2007; 26:88.</a></li><li><a class="nounderline abstract_t">van Hellemond JJ, Molhoek N, Koelewijn R, et al. Is paromomycin the drug of choice for eradication of Dientamoeba fragilis in adults? Int J Parasitol Drugs Drug Resist 2012; 2:162.</a></li><li><a class="nounderline abstract_t">Kurt O, Girginkardeşler N, Balcioğlu IC, et al. A comparison of metronidazole and single-dose ornidazole for the treatment of dientamoebiasis. Clin Microbiol Infect 2008; 14:601.</a></li><li><a class="nounderline abstract_t">Stark D, Roberts T, Marriott D, et al. Detection and transmission of Dientamoeba fragilis from environmental and household samples. Am J Trop Med Hyg 2012; 86:233.</a></li></ol></div><div id="topicVersionRevision">Topic 5720 Version 25.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31656115" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Optimization of routine microscopic and molecular detection of parasitic protozoa in SAF-fixed faecal samples in Sweden.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15258093" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Emerging from obscurity: biological, clinical, and diagnostic aspects of Dientamoeba fragilis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29404747" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Does Dientamoeba fragilis cause diarrhea? A systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25229421" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : The prevalence of intestinal parasites is not greater among individuals with irritable bowel syndrome: a population-based case-control study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25700890" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Case-control comparison of bacterial and protozoan microorganisms associated with gastroenteritis: application of molecular detection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32418381" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Dientamoeba fragilis Infection in Patients with Digestive and Non-Digestive Symptoms: A Case-Control Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31659566" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Distribution and relevance of Dientamoeba fragilis and Blastocystis species in gastroenteritis: results from a case-control study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8920018" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Dientamoeba fragilis shares a recent common evolutionary history with the trichomonads.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24808242" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Description of Dientamoeba fragilis cyst and precystic forms from human samples.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28697994" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Molecular epidemiology of Dientamoeba fragilis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29988175" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Study of the pathogenic potential of Dientamoeba fragilis in experimentally infected mice.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36552252" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Commensal Intestinal Protozoa-Underestimated Members of the Gut Microbial Community.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33633081" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Impact of Metronidazole Treatment and Dientamoeba Fragilis Colonization on Gut Microbiota Diversity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29915224" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Characteristics of the bacterial microbiome in association with common intestinal parasites in irritable bowel syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34613993" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Investigation of neglected protists Blastocystis sp. and Dientamoeba fragilis in immunocompetent and immunodeficient diarrheal patients using both conventional and molecular methods.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32198171" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Commensal Bacteria Impact a Protozoan's Integration into the Murine Gut Microbiota in a Dietary Nutrient-Dependent Manner.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31717479" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Two Drinking Water Outbreaks Caused by Wastewater Intrusion Including Sapovirus in Finland.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22515838" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Pigs as natural hosts of Dientamoeba fragilis genotypes found in humans.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35796090" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : First detection and molecular characterization of Dientamoeba fragilis in cattle.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33799948" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : One Health Approach to Zoonotic Parasites: Molecular Detection of Intestinal Protozoans in an Urban Population of Norway Rats, Rattus norvegicus, in Barcelona, Spain.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35467079" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : First report and genotyping of Dientamoeba fragilis in pet budgerigars (Melopsittacus undulatus), with zoonotic importance.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36499734" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : A Cross-Sectional Study on the Occurrence of the Intestinal Protist, Dientamoeba fragilis, in the Gut-Healthy Volunteers and Their Animals.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23893951" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Dientamoeba fragilis DNA detection in Enterobius vermicularis eggs.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23116599" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : DNA of Dientamoeba fragilis detected within surface-sterilized eggs of Enterobius vermicularis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34346875" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Investigation of Dientamoeba fragilis Frequency in Faecal Samples of Patients with Enterobius vermicularis Infection by Polymerase Chain Reaction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15956388" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Prospective study of the prevalence, genotyping, and clinical relevance of Dientamoeba fragilis infections in an Australian population.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31339096" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Dientamoeba fragilis - the most common intestinal protozoan in the Helsinki Metropolitan Area, Finland, 2007 to 2017.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36264933" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Challenges and costs of donor screening for fecal microbiota transplantations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6021735" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Parasitologic studies in a group of furloughed missionaries. I. Intestinal protozoa.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9183160" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Enteropathogens associated with diarrhea among military personnel during Operation Bright Star 96, in Alexandria, Egypt.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30328410" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Clinical and Epidemiological Characteristics of Patients with Dientamoeba fragilis Infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17241259" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Dientamoeba fragilis as a cause of travelers' diarrhea: report of seven cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24886502" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Intestinal parasitoses in a tertiary-care hospital located in a non-endemic setting during 2006-2010.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35134178" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Persistent abdominal symptoms in returning travellers: clinical and molecular findings.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9443114" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Dientamoeba fragilis masquerading as allergic colitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12588330" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Dientamoeba fragilis, a neglected cause of diarrhea, successfully treated with secnidazole.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7563257" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Descriptive features of Dientamoeba fragilis infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12691546" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Dientamoeba fragilis--a protozoal infection which may cause severe bowel distress.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1880405" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : On the clinical importance of Dientamoeba fragilis infections in childhood.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27170141" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Dientamoeba fragilis, the Neglected Trichomonad of the Human Bowel.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20348509" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : A review of the clinical presentation of dientamoebiasis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33137500" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Dientamoeba fragilis in the North-East of Italy: Prevalence study and treatment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10367400" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Incidence of Dientamoeba fragilis in faecal samples submitted for routine microbiological analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20532564" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Blastocystis hominis and Dientamoeba fragilis in patients fulfilling irritable bowel syndrome criteria.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28668983" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : The role of Blastocystis sp. and Dientamoeba fragilis in irritable bowel syndrome: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33978095" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Prevalence and genetic characterization of Dientamoeba fragilis in asymptomatic children attending daycare centers.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15991830" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Dientamoeba fragilis is more prevalent than Giardia duodenalis in children and adults attending a day care centre in Central Italy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2325352" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Dientamoeba fragilis infection, a cause of gastrointestinal symptoms in childhood.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23759351" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Dientamoeba fragilis: a family cluster of disease associated with marked peripheral eosinophilia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34116243" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Epidemiology and clinical features of intestinal protozoan infections detected by Real-time PCR in non-native children within an Italian tertiary care children's hospital: A cross-sectional study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15619516" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Detection of Dientamoeba fragilis in fresh stool specimens using PCR.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16390978" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Evaluation of three diagnostic methods, including real-time PCR, for detection of Dientamoeba fragilis in stool specimens.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21048004" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Evaluation of multiplex tandem real-time PCR for detection of Cryptosporidium spp., Dientamoeba fragilis, Entamoeba histolytica, and Giardia intestinalis in clinical stool samples.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20462728" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Evaluation of a real-time polymerase chain reaction assay for the detection of Dientamoeba fragilis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24131443" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Detection of intestinal protozoa in paediatric patients with gastrointestinal symptoms by multiplex real-time PCR.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28007484" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Diagnosis of intestinal parasites in a rural community of Venezuela: Advantages and disadvantages of using microscopy or RT-PCR.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29581055" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Evaluation of the Roche LightMix Gastro parasites multiplex PCR assay detecting Giardia duodenalis, Entamoeba histolytica, cryptosporidia, Dientamoeba fragilis, and Blastocystis hominis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24286625" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Evaluation of the EasyScreen™enteric parasite detection kit for the detection of Blastocystis spp., Cryptosporidium spp., Dientamoeba fragilis, Entamoeba complex, and Giardia intestinalis from clinical stool samples.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32326453" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Evaluation of the AllplexTM Gastrointestinal Panel-Parasite Assay for Protozoa Detection in Stool Samples: A Retrospective and Prospective Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1905055" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Dientamoeba fragilis detection methods and prevalence: a survey of state public health laboratories.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8024063" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Intestinal parasitism in the United States: update on a continuing problem.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9031881" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Prevalence of Dientamoeba fragilis antibodies in children and recognition of a 39 kDa immunodominant protein antigen of the organism.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16380293" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Dientamoebiasis: clinical importance and recent advances.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16380293" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Dientamoebiasis: clinical importance and recent advances.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24533282" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Current treatment options for Dientamoeba fragilis infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22024820" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : In vitro susceptibility testing of Dientamoeba fragilis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25148459" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Activity of benzimidazoles against Dientamoeba fragilis (Trichomonadida, Monocercomonadidae) in vitro and correlation of beta-tubulin sequences as an indicator of resistance.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24647023" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Metronidazole therapy for treating dientamoebiasis in children is not associated with better clinical outcomes: a randomized, double-blinded and placebo-controlled clinical trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17195717" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Treatment of Dientamoeba fragilis infection with paromomycin.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24533277" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Is paromomycin the drug of choice for eradication of Dientamoeba fragilis in adults?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18397330" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : A comparison of metronidazole and single-dose ornidazole for the treatment of dientamoebiasis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22302854" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Detection and transmission of Dientamoeba fragilis from environmental and household samples.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
